当前位置:首页 - 行情中心 - 鱼跃医疗(002223) - 财务分析 - 现金流量表

鱼跃医疗

(002223)

  

流通市值:352.00亿  总市值:375.33亿
流通股本:9.40亿   总股本:10.02亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金4,377,341,386.032,127,553,221.557,911,766,020.155,763,455,872.02
  收到的税费返还57,174,723.3323,009,010.6100,219,249.8282,153,601.9
  收到其他与经营活动有关的现金393,223,868.88208,087,948.97478,431,734.72466,760,647.32
  经营活动现金流入小计4,827,739,978.242,358,650,181.128,490,417,004.696,312,370,121.24
  购买商品、接受劳务支付的现金1,507,507,856.15689,182,265.853,371,976,640.072,420,961,830.98
  支付给职工以及为职工支付的现金734,821,553.48440,710,376.131,204,715,317.18941,000,453.6
  支付的各项税费551,976,450.39138,959,593.49723,038,891.21588,867,115.3
  支付其他与经营活动有关的现金866,573,440.88432,083,430.561,374,416,423.46979,245,309.57
  经营活动现金流出小计3,660,879,300.91,700,935,666.036,674,147,271.924,930,074,709.45
  经营活动产生的现金流量净额1,166,860,677.34657,714,515.091,816,269,732.771,382,295,411.79
二、投资活动产生的现金流量:
  收回投资收到的现金8,534,089.955,085,814.19292,782,166.91292,371,292.2
  取得投资收益收到的现金33,774,434.381,825,218.142,157,053.28164,054.79
  处置固定资产、无形资产和其他长期资产收回的现金净额75,419,373.4830,835,162.424,782,049.562,455,845.91
  收到的其他与投资活动有关的现金---2,834,641.7
  投资活动现金流入小计117,727,897.8137,746,194.75299,721,269.75297,825,834.6
  购建固定资产、无形资产和其他长期资产支付的现金60,684,869.5830,653,057.1128,430,788.0763,779,955.65
  投资支付的现金197,481,592.01202,197,929.35196,409,872.79131,749,818.58
  支付其他与投资活动有关的现金--379,200-
  投资活动现金流出小计258,166,461.59232,850,986.45325,219,860.86195,529,774.23
  投资活动产生的现金流量净额-140,438,563.78-195,104,791.7-25,498,591.11102,296,060.37
三、筹资活动产生的现金流量:
  吸收投资收到的现金--7,614,366-
  收到其他与筹资活动有关的现金9,701,657.12,500,00027,567,751.0645,937,944.98
  筹资活动现金流入小计9,701,657.12,500,00035,182,117.0645,937,944.98
  偿还债务支付的现金-01,207,381,841.411,182,137,500
  分配股利、利润或偿付利息支付的现金399,742,211.6401,224,455,405.04816,426,251.58
  支付其他与筹资活动有关的现金7,201,657.17,201,657.12,505,00027,053,273.92
  筹资活动现金流出小计406,943,868.747,201,657.12,434,342,246.452,025,617,025.5
  筹资活动产生的现金流量净额-397,242,211.64-4,701,657.1-2,399,160,129.39-1,979,679,080.52
四、汇率变动对现金及现金等价物的影响-12,673,315.72-1,663,513.5216,535,824.88-17,107,331.1
五、现金及现金等价物净增加额616,506,586.2456,244,552.77-591,853,162.85-512,194,939.46
  加:期初现金及现金等价物余额6,595,998,408.926,616,148,637.697,187,851,571.777,187,851,571.77
  期末现金及现金等价物余额7,212,504,995.127,072,393,190.466,595,998,408.926,675,656,632.31
补充资料:
  净利润1,199,667,055.45-1,804,266,349.2-
  资产减值准备36,206,550.48-68,065,855.47-
  固定资产和投资性房地产折旧94,490,375.5-186,746,337.57-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧94,490,375.5-186,746,337.57-
  无形资产摊销12,524,793.93-26,106,017.47-
  长期待摊费用摊销23,225,165.45-35,967,341.28-
  处置固定资产、无形资产和其他长期资产的损失-1,249,796.19--6,161,857.24-
  固定资产报废损失195,402.15-1,130,623.32-
  财务费用13,202,827.65--42,442,513.88-
  投资损失-32,692,343.07--23,206,208.79-
  递延所得税-5,200,031.3--139,107,785.14-
  其中:递延所得税资产减少-351,758.85-17,879,639.78-
    递延所得税负债增加-4,848,272.45--156,987,424.92-
  存货的减少262,423,239.04--23,737,497.55-
  经营性应收项目的减少-581,163,253.85--13,551,935.16-
  经营性应付项目的增加121,796,708.25--101,087,005.85-
  其他10,148,539.37-3,917,089.37-
  现金的期末余额7,212,504,995.12-6,595,998,408.92-
  减:现金的期初余额6,595,998,408.92-7,187,851,571.77-
  现金及现金等价物的净增加额616,506,586.2--591,853,162.85-
公告日期2025-08-232025-04-262025-04-262024-10-26
审计意见(境内)标准无保留意见
TOP↑